Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intensive Treatment for Chronic Pain and Posttraumatic Stress Disorder (PTSD)

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
VA Office of Research and Development Identifier:
First received: April 30, 2010
Last updated: April 18, 2016
Last verified: April 2016
This study is investigating the efficacy of an intensive (3 week) integrated treatment for Veterans with both pain and PTSD.

Condition Intervention
Stress Disorders, Post-Traumatic
Behavioral: Intensive Treatment

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Intensive Treatment of Chronic Pain and PTSD for OEF/OIF Veterans

Resource links provided by NLM:

Further study details as provided by VA Office of Research and Development:

Primary Outcome Measures:
  • The Clinician Administered Assessment of PTSD (CAPS) [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 102
Study Start Date: August 2010
Estimated Study Completion Date: December 2016
Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Arm 1
Intensive 3 week treatment for pain and PTSD
Behavioral: Intensive Treatment
Participants randomized to the PT condition will attend 6 bi-weekly outpatient therapy sessions conducted in an individual format of 90 minutes in duration.
No Intervention: Arm 2
treatment as usual

Detailed Description:


The primary objective of this study is to evaluate the efficacy of an intensive integrated treatment for Veterans with comorbid chronic pain and posttraumatic stress disorder (PTSD). A secondary objective is to examine potential mechanisms of action that might account for improvements in pain or PTSD. Third, exploratory analyses will be conducted to assess the relationship between participation in treatment and cognitive functioning. It is hypothesized that 1) participants receiving the intensive treatment (PT) will report significantly greater decreases in symptoms of pain and PTSD from pre-treatment to post-treatment when compared to participants randomized to a standard care (SC) condition, and 2) participants receiving PT will show greater maintenance of change on measures of pain and PTSD at 3 months following the completion of treatment when compared to participants randomized to the SC condition.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients will be eligible to participate if they have constant pain of at least three months duration with a neurologic or musculoskeletal etiology.
  • Patients must also meet diagnostic criteria for PTSD.

Exclusion Criteria:

  • Patients with life threatening or acute physical illness, current alcohol or substance abuse, current psychosis or suicidal ideation, and individuals seeking pain treatment such as surgical interventions will be excluded.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01120067

United States, Connecticut
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
West Haven, Connecticut, United States, 06516
United States, Massachusetts
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Boston, Massachusetts, United States, 02130
Sponsors and Collaborators
VA Office of Research and Development
Principal Investigator: John Otis, BS BA PhD VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
  More Information

Responsible Party: VA Office of Research and Development Identifier: NCT01120067     History of Changes
Other Study ID Numbers: D6281-I 
Study First Received: April 30, 2010
Last Updated: April 18, 2016
Health Authority: United States: Federal Government

Keywords provided by VA Office of Research and Development:
Stress Disorders, Post-Traumatic

Additional relevant MeSH terms:
Stress Disorders, Traumatic
Chronic Pain
Stress Disorders, Post-Traumatic
Trauma and Stressor Related Disorders
Mental Disorders
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms processed this record on December 05, 2016